Literature DB >> 17011634

Pathological gambling secondary to dopaminergic therapy in Parkinson's disease.

Dominique Drapier1, Sophie Drapier, Paul Sauleau, Pascal Derkinderen, Philippe Damier, Herve Allain, Marc Vérin, Bruno Millet.   

Abstract

We describe six patients with Parkinson's disease (PD) and pathological gambling. All patients started gambling after the onset of PD and initiation or increase of treatment with dopaminergic therapy. The fact that pathological behaviour disappeared as medication was ended or decreased suggests that an elaborate behavioural manifestation could be related to dopamine tone in patients with Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17011634     DOI: 10.1016/j.psychres.2006.04.017

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  4 in total

1.  Dopaminergic Medication in Parkinson's Disease and Problem Gambling.

Authors:  Jacqueline Olley; Alex Blaszczynski; Simon Lewis
Journal:  J Gambl Stud       Date:  2015-09

Review 2.  Behavioural adverse effects of dopaminergic treatments in Parkinson's disease: incidence, neurobiological basis, management and prevention.

Authors:  Angelo Antonini; Roberto Cilia
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 3.  Decision making in Parkinson's disease: An analysis of the studies using the Iowa Gambling Task.

Authors:  Laura Colautti; Paola Iannello; Maria Caterina Silveri; Alessandro Antonietti
Journal:  Eur J Neurosci       Date:  2021-11-09       Impact factor: 3.698

Review 4.  Pathological Gambling Associated With Aripiprazole or Dopamine Replacement Therapy: Do Patients Share the Same Features? A Review.

Authors:  Marie Grall-Bronnec; Anne Sauvaget; Fanny Perrouin; Juliette Leboucher; François Etcheverrigaray; Gaëlle Challet-Bouju; Louise Gaboriau; Pascal Derkinderen; Pascale Jolliet; Caroline Victorri-Vigneau
Journal:  J Clin Psychopharmacol       Date:  2016-02       Impact factor: 3.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.